Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 13.99 Billion | USD 31.47 Billion | 10.70% | 2022 |
The global protein characterization and identification market size were worth around $ 13.99 billion in 2022 and is predicted to grow to around $ 31.47 billion by 2030 with a compound annual growth rate (CAGR) of roughly 10.70% between 2023 and 2030.
The report analyzes the global protein characterization and identification of market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the protein characterization and identification industry.
Protein characterization is the process of finding chemical, physical, and biological specifications of protein. Protein identification is the process by which the protein contents of cellular and biological samples are found through examination by mass spectrometry. Protein characterization and identification is the way for examining the presence of proteins based on their molecular weight and charge. The use of protein characterization and identification is high for medical diagnosis, agricultural & ecological research, and drug detection & development. The research procedure finds application across end-use sections such as biotechnology, pharmaceutical, academic research institutes, and contract research organizations.
Rising investment in research & development of pharmaceutical & biotechnology companies is likely to boost global market growth.
The market for protein characterization and identification has been useful for important drug research and development. Protein analysis is a special stage in the development of pharmaceutical and biological products for finding viable candidates. Moreover, the acceptance of newly developed medication therapy has boosted the motivation to discover new and sophisticated drugs. Furthermore, the Pharmaceutical Research and Manufacturers of America (PhRMA) group is the representative of the leading biopharmaceutical research companies in the United States. Governments are promoting research in the bioinformatics industry by boosting funds.
Moreover, increased adoption of biologics and biomarkers is expected to drive the growth of the protein characterization and identification market. According to the March 2021 article, biologics and their delivery systems, trends in myocardial infarction, and current therapies do not adequately address some of the dysregulated systems after myocardial infarction. Therefore, recent studies have developed new biological delivery systems to tackle this disease. Research on the development of drug delivery systems for biologics is expected to increase during the forecast period, which will have a positive impact on the market growth.
High cost of the instrument can hamper the global industry expansion.
Modern protein characterization and identification techniques, which includes X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, cryo-electron microscopy, and mass spectrometry, depend heavily on sophisticated and high-end instrumentation. These instruments are regularly expensive to install, buy, and maintain, making them inaccessible for a few study establishments or smaller laboratories with limited budgets. Moreover, in addition to the continued preservation, preliminary funding, calibration, and upgrades of those units need good-sized economic sources. The expenses can be particularly burden for research facilities with high budgets, potentially hindering their ability to adopt the latest technologies and stay competitive in the field.
Rising application of proteomics in agriculture and food science is likely to generate new opportunities for global market growth.
The protein characterization and identification industry has an exciting opportunity to expand its reach into the fields of agriculture and food science, leveraging the potential of proteomics to enhance nutritional quality, crop productivity, and food safety. Proteomics is the large-scale study of proteins, providing valuable insights into the complex biological processes that control stress responses, plant growth, and interactions with the environment. In agriculture, understanding the proteomic profile of crops facilitates the development of genetically modified varieties that exhibit desirable traits such as drought resistance, disease resistance, and increased nutrient content. By identifying key proteins and signaling pathways associated with these traits, researchers can genetically modify specific genes or develop selective breeding strategies to improve crop performance.
Proteomics can also play a vital role in addressing food safety issues. Contaminants, allergens, and adulterants in food can be detected and quantified through protein analysis to ensure safe and high-quality food is delivered to consumers. Identifying potentially allergenic proteins in food sources can help prevent allergic reactions while monitoring protein profiles can detect fraud such as mislabeling or adulteration. Moreover, in 2021, Thermos Fisher Scientific acquired Life Sciences Analytical Services (LSAS). LSAS is a leading provider of proteomics services, and this acquisition will help Thermos Fisher Scientific expand its proteomics offerings.
Lack Of skilled professionals can be a challenging task in the growth of the industry across the globe.
The inadequacy of skilled professionals for protein characterization and identification is one of the major challenges faced by the industry players. Sample preparation is an important step in isolating the desired analyte and helping to eliminate involvement, that could affect the result. Lack of knowledge about proper technology selection and sample preparation also affects the results and causes some direct and indirect costs for the end user. Hence, these factors are affecting the overall growth of the protein characterization and identification market.
The global protein characterization and identification market is segmented based on product & services, application, end-user, and region.
Based on the product & services, the global market is bifurcated into consumables, instruments, and services. The consumable segment is expected to capture the largest revenue share over the forecast period. Consumables refer to the materials and reagents used to include sample preparation, proteomic workflows, mass spectrometry analysis, and protein separation. This segment encompasses a wide range of products, such as chromatography enzymes, columns, gels, buffers, antibodies, and assay kits. The increasing adoption of proteomic technologies in pharmaceutical development, research, and clinical diagnostics drives the demand for high-quality and specialized consumables.
Based on the application, the protein characterization and identification industry is fragmented into clinical diagnosis, drug discovery, development, and other applications. The drug discovery segment is expected to capture the largest revenue share over the forecast period. Drug discovery aims to identify new therapeutic targets and develop effective drugs for various diseases, including cancer, cardiovascular disorders, neurological conditions, and infectious diseases. Proteomics performs an important position in this process with the aid of presenting complete insights into the complicated biological approaches underlying disease pathogenesis. Furthermore, identifying new therapeutic targets and developing effective drugs will drive segmental growth.
Based on the end users, the market is subdivided into contract research organizations, academic research institutions, pharmaceutical & biotechnology companies, and others. The pharmaceutical & biotechnology companies segment is expected to capture the largest revenue share over the forecast period. Pharmaceutical & biotechnology companies in the protein characterization and identification industry have an increasing focus on personalized medicine and precision therapeutics. Proteomics allows these companies to analyze individual patient samples, identifying disease-specific protein biomarkers, and thus tailoring treatments based on a patient's unique protein profile. This personalized approach holds the promise of improved treatment outcomes and reduced adverse effects, driving the adoption of proteomic technologies in drug development. For instance, Thermo Fisher Scientific company is a leading provider of protein characterization and identification products and services. In 2021, Thermo Fisher Scientific acquired Life Sciences Analytical Services (LSAS), a leading provider of proteomics services.
Report Attributes | Report Details |
---|---|
Report Name | Protein Characterization and Identification Market |
Market Size in 2022 | USD 13.99 Billion |
Market Forecast in 2030 | USD 31.47 Billion |
Growth Rate | CAGR of 10.70% |
Number of Pages | 216 |
Key Companies Covered | Promega Corporation Merck KGAA, Horiba, Jeol, PerkinElmer, Qiagen, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific, Agilent Technologies, Analytik Jena, Bio-Rad Laboratories, Bruker Corporation, Cleaver Scientific, Danaher Corporation, Eurofins Scientific, Waters Corporation, and others. |
Segments Covered | By product & services, By Application, By End Use, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2023 - 2030 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America to establish its domination in the global market over 2023-2030
North America is the largest market for protein characterization and identification, accounting for a share of around 35% in 2022. The presence of leading players, the availability of funding for breakthrough technologies by government organizations, and the increased R&D spending in proteomics are the main drivers behind the expansion of the protein characterization and identification industry in the region. For instance, in August 2021, Metrohm USA and Canada, both manufacturers of high-precision instruments, signed a partnership agreement with Agilent to be a re-seller for varied products & services being offered.
Europe is the second-largest market for protein characterization and identification, accounting for a share of around 25% in 2022. The growth of the market in this region is driven by the increasing government funding for proteomics research and the presence of a large number of leading proteomics companies.
The global protein characterization and identification market is dominated by players like:
By product & services
By Application
By End Use
FrequentlyAsked Questions
Protein characterization is the process of finding chemical, physical, and biological specifications of protein. Protein identification is the process by which the protein contents of cellular and biological samples are found through interrogation by mass spectrometry. Protein characterization and identification is the way for examining the presence of proteins based on their molecular weight and charge.
The rising investment in research & development of pharmaceutical & biotechnology companies particularly in developing countries drives the protein characterization and identification market growth over the forecast period.
According to the report, the global protein characterization and identification market size was worth around $ 13.99 billion in 2022 and is predicted to grow to around $ 31.47 billion by 2030.
The global protein characterization and identification market is expected to grow at a CAGR of 10.70% during the forecast period.
The global protein characterization and identification market growth is expected to be driven by North America due to its well-established pharmaceutical & biotechnology industry, strong research infrastructure, and significant investments in cutting-edge proteomic technologies.
The global protein characterization and identification market is dominated by players like Promega Corporation Merck KGAA, Horiba, Jeol, PerkinElmer, Qiagen, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific, Agilent Technologies, Analytik Jena, Bio-Rad Laboratories, Bruker Corporation, Cleaver Scientific, Danaher Corporation, Eurofins Scientific, and Waters Corporation.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed